Amber Davis, APRN | |
900 E 13th St Ste 200, Grove, OK 74344-2976 | |
(918) 592-0999 | |
Not Available |
Full Name | Amber Davis |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 10 Years |
Location | 900 E 13th St Ste 200, Grove, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366841702 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 93031 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Integris Grove Hospital | Grove, OK | Hospital |
Integris Miami Hospital | Miami, OK | Hospital |
Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ahs Oklahoma Heart Llc | 4587737135 | 109 |
News Archive
A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in just 30 to 45 minutes, according to a new study published June 12, 2020 in the open-access journal PLOS ONE by Laura Lamb of the Beaumont Health System, Michigan, USA, and colleagues.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Research studies show that Black patients can be subjected to wait times 30% longer than other patients at doctors' offices and other healthcare facilities, leaving little doubt about the biased nature of healthcare scheduling systems.
A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
› Verified 7 days ago
Entity Name | Ahs Oklahoma Heart Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in just 30 to 45 minutes, according to a new study published June 12, 2020 in the open-access journal PLOS ONE by Laura Lamb of the Beaumont Health System, Michigan, USA, and colleagues.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Research studies show that Black patients can be subjected to wait times 30% longer than other patients at doctors' offices and other healthcare facilities, leaving little doubt about the biased nature of healthcare scheduling systems.
A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Amber Davis, APRN 900 E 13th St Ste 200, Grove, OK 74344-2976 Ph: (918) 592-0999 | Amber Davis, APRN 900 E 13th St Ste 200, Grove, OK 74344-2976 Ph: (918) 592-0999 |
News Archive
A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in just 30 to 45 minutes, according to a new study published June 12, 2020 in the open-access journal PLOS ONE by Laura Lamb of the Beaumont Health System, Michigan, USA, and colleagues.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Research studies show that Black patients can be subjected to wait times 30% longer than other patients at doctors' offices and other healthcare facilities, leaving little doubt about the biased nature of healthcare scheduling systems.
A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
› Verified 7 days ago
Ms. Dorothy Ann Mayes, ARNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1121 Neo Loop, Grove, OK 74344 Phone: 918-786-8448 Fax: 918-786-3483 | |
Christopher Gray, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 E 13th St, Grove, OK 74344 Phone: 918-786-1909 | |
Emily Ann Chandler, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 E 13th St, Grove, OK 74344 Phone: 918-786-1909 Fax: 918-787-3866 | |
Kaci Kretchmar, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 E 18th St, Grove, OK 74344 Phone: 918-786-2243 | |
Joseph James Gelinas, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 S Broadway St, Grove, OK 74344 Phone: 918-786-0800 Fax: 918-786-0876 | |
Shealyn Berry, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 E 13th St Ste Acgh, Grove, OK 74344 Phone: 918-786-9009 |